AKAP12 and breast cancer: The siRNA-mediated knockdown of human SSeCKS/AKAP12 in DU145 prostate cancer cells resulted in increased chemotaxis to serum, whereas its overexpression in MDA-MB-231 breast cancer cells inhibited chemotaxis (Fig. 1A).